Levi & Korsinsky Reminds Iovance Biotherapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 14, 2025 – IOVA
(NasdaqGM:IOVA), NEW YORK, July 03, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Iovance Biotherapeutics, Inc. (“Iovance” or the “Company”) (NASDAQ: IOVA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Iovance investors who were adversely affected by alleged securities fraud between May 9, […]